Mounjaro (tirzepatide) is a once-weekly injection approved by the FDA for adults with type 2 diabetes, and for children aged 10 and older, to improve blood sugar control. Its main benefit is better glycemic control; it also lowers the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk. Its most common side effects are digestive, such as nausea and diarrhea. Weight loss is a known effect, but Mounjaro is not approved for it.
The FDA-approved uses come from the Mounjaro prescribing information, section 1. The same active ingredient is sold for weight management and sleep apnea as Zepbound, covered below. Your prescriber decides which medicine fits you.
How Mounjaro works
Tirzepatide activates two receptors instead of one. According to the label (section 12.1), it is a GIP receptor and GLP-1 receptor agonist. It binds to and activates both, which raises insulin release and lowers glucagon in a glucose-dependent way. It also lowers fasting and after-meal glucose and decreases food intake (prescribing information, section 12).
Semaglutide, the ingredient in Ozempic and Wegovy, acts on the GLP-1 receptor only (Ozempic prescribing information, section 12.1). For a head-to-head look, see Mounjaro vs Ozempic.
Mounjaro dosing schedule
| Step | Weekly dose | How long |
|---|---|---|
| Start | 2.5 mg | Starting dose |
| Increase (if more blood sugar control is needed) | Up in 2.5 mg steps | After at least 4 weeks on the current dose |
| Maximum, adults | 15 mg | n/a |
| Maximum, ages 10 to 17 | 10 mg | n/a |
Source: Mounjaro prescribing information, section 2.1. It is injected under the skin of the abdomen or thigh, or into the back of the upper arm by another person, any time of day, with or without food, and sites should be rotated (section 2.2). If a dose is missed, the label says to take it as soon as possible within 4 days (96 hours); after that, skip it and take the next one on the usual day (section 2.1). Your doctor sets your actual path.
What the trials show
Mounjaro’s label is built on diabetes trials. In a 40-week trial of 1,879 adults with type 2 diabetes (SURPASS-2), tirzepatide lowered HbA1c by 2.01 to 2.30 percentage points depending on dose, versus 1.86 with semaglutide 1 mg, and weight fell more with tirzepatide than with semaglutide (by 1.9 to 5.5 kg more, depending on dose) (NEJM 2021, PubMed).
For weight loss in people without diabetes, the relevant label is Zepbound’s. At 72 weeks, the average weight change was -3.1% with placebo and -15.0%, -19.5% and -20.9% with 5 mg, 10 mg and 15 mg (Zepbound prescribing information, section 14). These are trial averages with a lifestyle program; individual results vary. For more on that version, read our Zepbound guide and Zepbound dosage schedule.
Side effects and warnings
The label lists these most common adverse reactions (reported by 5% or more of patients): nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia and abdominal pain. The slow dose increase is meant to reduce them. The warnings and precautions section also names:
- Thyroid C-cell tumors (boxed warning): seen in rats; unknown whether it happens in humans. Mounjaro must not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2.
- Acute pancreatitis, acute gallbladder disease and serious stomach and bowel reactions (not recommended in severe gastroparesis).
- Low blood sugar when combined with insulin or sulfonylureas.
- Kidney injury from dehydration after vomiting or diarrhea, serious allergic reactions, and worsening diabetic retinopathy.
- Pulmonary aspiration during anesthesia: tell your care team before any procedure.
- Women using oral contraceptives are advised to switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase.
Call your prescriber about severe or lasting stomach pain, repeated vomiting, or anything that worries you. For management tips, see GLP-1 side effects: what to expect and how to manage them. This is general information, not medical advice.
What we don’t know yet
The trials cited above ran for 40 to 72 weeks, so long-term questions remain open. Ask your prescriber what the plan is for how long you will take the medicine and what happens if you stop.
Tracking Mounjaro
A simple log makes dose increases and side effects easier to discuss at appointments: injection day, dose and site, side effects and when they started, meals and protein, and weight. Mingo is a GLP-1 tracker for iPhone and Android that keeps shots, food, side effects and weight in one place. It doesn’t replace your doctor. Get the app.
Key takeaways
- Mounjaro (tirzepatide) is approved for type 2 diabetes; the weight-management version is Zepbound.
- It activates both GIP and GLP-1 receptors; semaglutide activates GLP-1 only.
- Doses start at 2.5 mg weekly and rise in 2.5 mg steps no sooner than every 4 weeks, up to 15 mg in adults.
- Nausea, diarrhea, vomiting and constipation are the most common side effects; the label also carries a boxed thyroid tumor warning.
Frequently asked questions
What is Mounjaro used for?
Mounjaro is approved to improve blood sugar control in adults and children aged 10 and older with type 2 diabetes, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes at high risk. It is not approved for weight loss; Zepbound, which contains the same ingredient, is.
What are common side effects of Mounjaro?
Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain are the most common ones listed on the label. Serious but less common problems include pancreatitis and gallbladder disease. Tell your prescriber if symptoms are severe or don’t improve.
Is Mounjaro safe for weight loss?
Mounjaro itself isn’t approved for weight loss, and whether any GLP-1 or GIP medicine is appropriate for you depends on your health history. People with a personal or family history of medullary thyroid carcinoma or MEN 2 must not use it. Talk to a prescriber about the right option.
How does Mounjaro work in the body?
It activates the GIP and GLP-1 receptors, which increases insulin release when blood sugar is high, lowers glucagon and reduces food intake.
How much does Mounjaro cost?
Price depends on your country, insurance and pharmacy, and we don’t quote one here. Ask your pharmacist or insurer for current information.
